The Dow and S&P 500 ended a volatile session up slightly on Monday in a late turnaround, but a drop in biotechs and energy shares kept a lid on the market.
The start of earnings season added to investor nervousness. The Nasdaq ended lower, led by a drop in biotech company Celgene, which fell 5.5 percent to USD 103.03 following a disappointing profit forecast.
The Nasdaq Biotech index fell 3.4 percent in its eighth straight down day.
For 2 Days Free Trial, please visit our site at www.marketmagnify.com/aboutus.php
The start of earnings season added to investor nervousness. The Nasdaq ended lower, led by a drop in biotech company Celgene, which fell 5.5 percent to USD 103.03 following a disappointing profit forecast.
The Nasdaq Biotech index fell 3.4 percent in its eighth straight down day.
For 2 Days Free Trial, please visit our site at www.marketmagnify.com/aboutus.php
No comments:
Post a Comment